Where does D. Western Therapeutics Institute, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), D. Western Therapeutics Institute, Inc. ranks #46,011 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does D. Western Therapeutics Institute, Inc. hold?

D. Western Therapeutics Institute, Inc. holds 5 US utility patents granted between 2015 and 2025, spanning 6 technology areas.

What is D. Western Therapeutics Institute, Inc.'s Innovation Score?

D. Western Therapeutics Institute, Inc. has an Innovation Score of 39.9 out of 100 (top 37% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does D. Western Therapeutics Institute, Inc. focus on?

D. Western Therapeutics Institute, Inc.'s top technology area is C07D (Heterocyclic Compounds) with 4 patents, ranking #1,646 of 3,165 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is D. Western Therapeutics Institute, Inc.'s patent grant rate increasing or decreasing?

D. Western Therapeutics Institute, Inc.'s recent grant velocity is +200% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for D. Western Therapeutics Institute, Inc.'s patents?

D. Western Therapeutics Institute, Inc.'s patents average 8.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the D. Western Therapeutics Institute, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

D. Western Therapeutics Institute, Inc.

USPTO PatentsView assignee record - 5 granted patents across 6 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, D. ranks #46,011 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 6 technology areas.

#46,011
of 49,997 US assignees by volume: Top 37%
by Innovation Score (39.9/100): 8.4
avg claims per patent: +200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R46011 · Foreign Corporation #46,011 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #46,011/49,997
PHOTO-FINISH D and M Asset…
CPC-NARROW C07D · 6 areas
INNOV-THIN 39.9/100
CLAIMS-PAR 8.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +200% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: D and M Asset Management, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How D.’s 39.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (16%) Velocity 20.0 pts (50%) Breadth 8.7 pts (22%) Claim depth 5.0 pts (13%)

Qualcomm Incorporated · highest

85
D Western Therapeuti… · this assignee

40
3D Lighting… · lowest

7

What this shows D.'s Innovation Score is 39.9/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for D.?

Each dot is one of D.’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). D.’s own 8.4 claims/patent is at or below the 14.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

D. vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where D.'s grants concentrate

D. Western Therapeutics Institute, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 80% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2015. By volume, D. sits between D Morrison Consulting Inc. and Dagang OIL Field Company OF Cnpc.

D.'s three-year grant acceleration

D. Western Therapeutics Institute, Inc. shows 3 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

D Morrison Consul…

5
D and M Asset Man…

5
D&B Business Info…

5
D-tech UK

5
D8ai

5
Daemo Engineering

5
Daewon Industry

5
Dagang OIL Field…

5
D Western Therape… ◀

5

What this shows D. holds 5 patents at rank #46,016, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near D

By rank, the assignees closest to #46,016 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in D's primary technology class.

D.'s Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 37% higher than 63% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

D. Western Therapeutics Institute, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	20.0%
2022	3	60.0%
2025partial year	1	20.0%

Which technologies does D. Western Therapeutics Institute, Inc. patent most?

C07D - Heterocyclic Compounds 4

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 1

C09B - Organic Dyes OR Closely-related Compounds FOR Producing Dyes ; , e.g. PIGMENTS; MORDANTS; Lakes 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

D. Western Therapeutics Institute, Inc.'s patent record in context - here's where to go next.

D. Western Therapeutics Institute, Inc.'s lead technology class is C07D (Heterocyclic Compounds), 80% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #46,011 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare D. Western Therapeutics Institute, Inc. against D Morrison Consulting Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.